4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose level 4D-150 demonstrated durable and dose-dependent clinical activity with sustained gains in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback